These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 7441646)

  • 1. N-acetyl-D-galactosamine blocks activation of murine macrophages to inhibit tumor cell growth.
    Thomasson DL; Stewart CC
    J Reticuloendothel Soc; 1980 Nov; 28(5):449-56. PubMed ID: 7441646
    [No Abstract]   [Full Text] [Related]  

  • 2. N-bromoacetyl-beta-D-glucosamine tetra-O-acetate and N-bromoacetyl-beta-D-galactosamine tetra-O-acetate as chemotherapeutic agents with immunopotentiating effects in Ehrlich ascites tumor-bearing mice.
    Simon P; Burlingham WJ; Conklin R; Fondy TP
    Cancer Res; 1979 Oct; 39(10):3897-902. PubMed ID: 476625
    [No Abstract]   [Full Text] [Related]  

  • 3. N-acetyl-D-galactosamine inhibits TNF-alpha gene expression induced in mouse peritoneal macrophages by fimbriae of Porphyromonas (Bacteroides) gingivalis, an oral anaerobe.
    Murakami Y; Hanazawa S; Nishida K; Iwasaka H; Kitano S
    Biochem Biophys Res Commun; 1993 Apr; 192(2):826-32. PubMed ID: 8097914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of N-acetyl-beta-D-galactosamine-specific lectin to Fc receptor-mediated phagocytosis by mouse peritoneal macrophages.
    Aramaki Y; Murai M; Tsuchiya S
    Immunology; 1993 Jul; 79(3):403-7. PubMed ID: 8406569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-agent chemotherapy of a solid murine tumor assayed by growth delay and cell survival.
    Begg AC; Fu KK; Kane LJ; Phillips TL
    Cancer Res; 1980 Jan; 40(1):145-54. PubMed ID: 7349894
    [No Abstract]   [Full Text] [Related]  

  • 6. Macrophage activation for tumor cytotoxicity: analysis of cellular lipid and fatty acid content during lymphokine activation.
    Schlager SI; Meltzer MS
    J Reticuloendothel Soc; 1981 Mar; 29(3):227-40. PubMed ID: 7218233
    [No Abstract]   [Full Text] [Related]  

  • 7. Selective inhibition of tumor cell migration by culture supernatants derived from normal and lipopolysaccharide activated macrophages.
    Young MR; Cheung HT; Sundharadas G
    J Reticuloendothel Soc; 1980 Feb; 27(2):143-50. PubMed ID: 7359508
    [No Abstract]   [Full Text] [Related]  

  • 8. Proliferative and vascular responses to cytoreduction in solid tumor models.
    Braunschweiger PG
    Prog Clin Biol Res; 1990; 354A():31-46. PubMed ID: 2247494
    [No Abstract]   [Full Text] [Related]  

  • 9. The effects of vasodilating drugs on pH in tumors.
    Adachi E; Tannock IF
    Oncol Res; 1999; 11(4):179-85. PubMed ID: 10566616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic advantage from combining paclitaxel with the hypoxia-selective cytotoxin NLCQ-1 in murine tumor- or human xenograft-bearing mice.
    Papadopoulou MV; Ji M; Ji X; Bloomer WD; Hollingshead MG
    Cancer Chemother Pharmacol; 2002 Dec; 50(6):501-8. PubMed ID: 12451478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of characterization of a continuous line of alveolar macrophages from C3H/HEJ mice.
    Cahoon BE; Mills J
    J Reticuloendothel Soc; 1981 May; 29(5):357-67. PubMed ID: 6165824
    [No Abstract]   [Full Text] [Related]  

  • 12. Potential chemoprotectant activity of mechanism-based glycosidase inhibitors against ricin toxicity in Chinese hamster ovary and macrophage J774A.1 cell cultures.
    Hassoun EA; Bagchi D; Roche VF; Stohs SJ
    J Appl Toxicol; 1996; 16(1):49-54. PubMed ID: 8821675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective transformation of host lymphocytes in vivo by retrovirus-producing macrophages.
    Bosco MC; Musso T; Gusella GL; Giovarelli M; Forni M; Soleti A; Masuelli L; Modesti A; Forni G; Varesio L
    J Immunol; 1993 Jan; 150(1):278-89. PubMed ID: 8417128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phytohemagglutinin effects on cultured human neural crest tumors.
    Helson L
    In Vitro; 1979 Aug; 15(8):565-8. PubMed ID: 511204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of macrophages and cytokines into rejection mechanism of the drug-resistant and immunogenic murine lymphoma P388/adria.
    Kisseleva E; Becker M; Lemm M; Fichtner I
    Anticancer Res; 1996; 16(4A):1971-8. PubMed ID: 8712729
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective cytokine inhibitory drugs with enhanced antiangiogenic activity control tumor growth through vascular inhibition.
    Gee MS; Makonnen S; al-Kofahi K; Roysam B; Payvandi F; Man HW; Muller GW; Lee WM
    Cancer Res; 2003 Dec; 63(23):8073-8. PubMed ID: 14678955
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of a monoclonal antibody recognizing 3-deoxy-D-manno-2-octulosonic acid on endotoxin-induced activation of pre-B cells and macrophages.
    Pedron T; Girard R; Lasfargues A; Chaby R
    Cell Immunol; 1993 Apr; 148(1):18-31. PubMed ID: 8495486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ras-induced neoplastic transformation and sensitivity to tumor necrosis factor.
    Fernandez A; Chen PW; Ananthaswamy HN
    Anticancer Res; 1994; 14(6B):2649-52. PubMed ID: 7872696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of macrophages in skeletal muscle regeneration with particular reference to chemotaxis.
    Robertson TA; Maley MA; Grounds MD; Papadimitriou JM
    Exp Cell Res; 1993 Aug; 207(2):321-31. PubMed ID: 8344384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacterial DNA causes septic shock.
    Sparwasser T; Miethke T; Lipford G; Borschert K; Häcker H; Heeg K; Wagner H
    Nature; 1997 Mar; 386(6623):336-7. PubMed ID: 9121548
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.